Skip to main content

BLACKBERRY Ltd

For the period ended Nov 30, 2024. Filed Dec 20, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Nov 30, 2024 · Filed Dec 20, 2024

BB$8.74+4.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. Financial Statements

Consolidated Balance Sheets as of November 30, 2024 (unaudited) and February 29, 20245
Consolidated Statements of Shareholders' Equity - Three and Nine Months Ended November 30, 2024 and 2023 (unaudited)7
Consolidated Statements of Operations - Three and Nine Months Ended November 30, 2024 and 2023 (unaudited)8
Consolidated Statements of Comprehensive Loss - Three and Nine Months Ended November 30, 2024 and 2023 (unaudited)9
Consolidated Statements of Cash Flows - Nine Months Ended November 30, 2024 and 2023 (unaudited)10
Notes to the Consolidated Financial Statements11
Item 2Management's Discussion and Analysis of Financial Condition and Results of Operations34
Item 3Quantitative and Qualitative Disclosures about Market Risk65
Item 4Controls and Procedures66
PART IIOTHER INFORMATION
Item 1Legal Proceedings66
Item 6Exhibits67
Signatures68

Unless the context otherwise requires, all references to the “Company” and “BlackBerry” include BlackBerry Limited and its subsidiaries.

PART I - FINANCIAL INFORMATION

Incorporated under the Laws of Ontario

Consolidated Balance Sheets

As at
November 30, 2024February 29, 2024
Assets
Current
Cash and cash equivalents (note 3)$189$175
Short-term investments (note 3)3162
Accounts receivable, net of allowance of $6 and $6, respectively (note 4)161179
Other receivables (note 4)619
Income taxes receivable54
Other current assets (note 4)3932
Assets held for sale, current (note 2)2437
455508
Restricted cash and cash equivalents (note 3)1125
Long-term investments (note 3)3536
Other long-term assets (note 4)7354
Operating lease right-of-use assets, net2122
Property, plant and equipment, net (note 4)1419
Intangible assets, net (note 4)5158
Goodwill (note 4)473475
Assets held for sale, non-current (note 2)176198
$1,309$1,395
Liabilities
Current
Accounts payable$9$16
Accrued liabilities (note 4)97100
Income taxes payable (note 5)3328
Deferred revenue, current (note 11)133148
Liabilities held for sale, current (note 2)6064
332356
Deferred revenue, non-current (note 11)1015
Operating lease liabilities1919
Other long-term liabilities13
Long-term notes (note 6)195194
Liabilities held for sale, non-current (note 2)2732
584619
Commitments and contingencies (note 10)
Shareholders’ equity
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable——
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares
Issued and outstanding - 591,583,200 voting common shares (February 29, 2024 - 589,232,539)2,9722,948
Deficit(2,230)(2,158)
Accumulated other comprehensive loss (note 9)(17)(14)
725776
$1,309$1,395

On behalf of the Board:

John GiamatteoLisa Disbrow
DirectorDirector

Consolidated Statements of Shareholders’ Equity

Three Months Ended November 30, 2024
Capital Stockand AdditionalPaid-in CapitalDeficitAccumulatedOtherComprehensive LossTotal
Balance as at August 31, 2024$2,964$(2,219)$(13)$732
Net loss—(11)—(11)
Other comprehensive loss——(4)(4)
Stock-based compensation6——6
Shares issued:
Employee share purchase plan2——2
Balance as at November 30, 2024$2,972$(2,230)$(17)$725
Three Months Ended November 30, 2023
Capital Stockand AdditionalPaid-in CapitalDeficitAccumulatedOtherComprehensive LossTotal
Balance as at August 31, 2023$2,931$(2,081)$(21)$829
Net loss—(21)—(21)
Other comprehensive income——77
Stock-based compensation8——8
Shares issued:
Employee share purchase plan2——2
Balance as at November 30, 2023$2,941$(2,102)$(14)$825

Consolidated Statements of Shareholders’ Equity

Nine Months Ended November 30, 2024
Capital Stockand AdditionalPaid-in CapitalDeficitAccumulatedOtherComprehensive LossTotal
Balance as at February 29, 2024$2,948$(2,158)$(14)$776
Net loss—(72)—(72)
Other comprehensive loss——(3)(3)
Stock-based compensation (note 7)21——21
Shares issued:
Employee share purchase plan (note 7)3——3
Balance as at November 30, 2024$2,972$(2,230)$(17)$725
Nine Months Ended November 30, 2023
Capital Stockand AdditionalPaid-in CapitalDeficitAccumulatedOtherComprehensive LossTotal
Balance as at February 28, 2023$2,909$(2,028)$(24)$857
Net loss—(74)—(74)
Other comprehensive income——1010
Stock-based compensation28——28
Shares issued:
Employee share purchase plan4——4
Balance as at November 30, 2023$2,941$(2,102)$(14)$825

(United States dollars, in millions, except per share data) (unaudited)

Consolidated Statements of Operations

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Revenue (note 11)$143$152$391$606
Cost of sales3133102239
Gross margin112119289367
Operating expenses
Research and development27298598
Sales and marketing23256877
General and administrative3845111133
Amortization461422
Impairment of long-lived assets (note 3)1949
Prior Debentures fair value adjustment (note 6)—(13)—3
93101282342
Operating income1918725
Investment income, net (note 3 and note 6)—5815
Income before income taxes19231540
Provision for income taxes (note 5)7151620
Income (loss) from continuing operations128(1)20
Loss from discontinued operations, net of tax (note 2)(23)(29)(71)(94)
Net loss$(11)$(21)$(72)$(74)
Earnings (loss) per share (note 8)
Basic earnings per share from continuing operations$0.02$0.01$—$0.03
Total basic loss per share$(0.02)$(0.04)$(0.12)$(0.13)
Diluted earnings (loss) per share from continuing operations$0.02$(0.01)$—$0.03
Total diluted loss per share$(0.02)$(0.05)$(0.12)$(0.13)

Consolidated Statements of Comprehensive Loss

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Net loss$(11)$(21)$(72)$(74)
Other comprehensive income (loss)
Net change in fair value and amounts reclassified to net loss from derivatives designated as cash flow hedges during the period, net of income taxes of nil for the three and nine months ended November 30, 2024 and November 30, 2023 (note 9)(1)—(1)1
Foreign currency translation adjustment(3)1(2)3
Net change in fair value from instrument-specific credit risk on the Prior Debentures, net of income taxes of nil for the three and nine months ended November 30, 2024 and November 30, 2023 (note 6)—6—6
Other comprehensive income (loss)(4)7(3)10
Comprehensive loss$(15)$(14)$(75)$(64)

Consolidated Statements of Cash Flows

Nine Months Ended
November 30, 2024November 30, 2023
Cash flows from operating activities
Net loss$(72)$(74)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization3946
Stock-based compensation2128
Impairment of long-lived assets (note 3)411
Intellectual property disposed of by sale—147
Prior Debentures fair value adjustment (note 6)—3
Operating leases(8)(7)
Net changes in working capital items
Accounts receivable, net of allowance27(63)
Other receivables134
Income taxes receivable(1)(2)
Other assets(22)(58)
Accounts payable(7)(7)
Accrued liabilities5(16)
Income taxes payable513
Deferred revenue(29)(13)
Net cash provided by (used in) operating activities(25)12
Cash flows from investing activities
Acquisition of long-term investments—(2)
Acquisition of property, plant and equipment(3)(5)
Acquisition of intangible assets(6)(12)
Acquisition of short-term investments(92)(92)
Proceeds on sale or maturity of short-term investments123223
Net cash provided by investing activities22112
Cash flows from financing activities
Issuance of common shares34
Maturities of 2020 Debentures (note 6)—(365)
Issuance of Extension Debentures (note 6)—150
Net cash used in financing activities3(211)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents during the period—(87)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period200322
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period$200$235
  1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND CRITICAL ACCOUNTING ESTIMATES

Basis of Presentation and Preparation

These interim consolidated financial statements have been prepared by management in accordance with United States generally accepted accounting principles (“U.S. GAAP”). They do not include all of the disclosures required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited consolidated financial statements of BlackBerry Limited (the “Company”) for the year ended February 29, 2024 (the “Annual Financial Statements”), which have been prepared in accordance with U.S. GAAP. In the opinion of management, all normal recurring adjustments considered necessary for fair presentation have been included in these interim consolidated financial statements. Operating results for the three and nine months ended November 30, 2024 are not necessarily indicative of the results that may be expected for the full year ending February 28, 2025. The consolidated balance sheet at February 29, 2024 was derived from the audited Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements.

The preparation of the consolidated financial statements requires management to make estimates and assumptions with respect to the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. Actual results could differ from these estimates and any such differences may be material to the Company’s consolidated financial statements.

Certain of the comparative figures have been reclassified to conform to the current year’s presentation, including for held for sale and discontinued operation, as further discussed in Note 2 and facilities discussed below. The Company reclassified all expenses associated with its facilities within General and administrative expenses, whereas previously these costs were allocated amongst the functional expense areas of the business based on assumptions of usage of those facilities by the functional areas.

The impact of the change on previously issued financial statements was as follows for the three and nine months ended November 30, 2023:

Three Months Ended · Nine Months Ended
RevisedRevised
November 30, 2023Impact of changeNovember 30, 2023November 30, 2023Impact of changeNovember 30, 2023
Cost of Sales48(2)46289(6)283
Gross Margin12721293916397
Research and development42(3)39146(10)136
Sales and marketing42(2)40131(7)124
General and administrative4375012723150
Cybersecurity
Segment cost of sales37(1)36110(4)106
Segment gross margin771781764180
IoT
Segment cost of sales9(1)826(2)24
Segment gross margin461471232125

The Company is organized and managed asthree reportable operating segments: Secure Communications (formerly “Cybersecurity”), IoT (and, collectively with Cybersecurity, “Software & Services”), and Licensing, as further discussed in Note 11.

Significant Accounting Policies and Critical Accounting Estimates

There have been no material changes to the Company’s accounting policies or critical accounting estimates from those described in the Annual Financial Statements with the exception of the below:

Assets held for sale and discontinued operations

When certain criteria are met, the Company reclassifies assets and related liabilities as held for sale at the lower of their carrying value or fair value less costs to sell and, if material, presents them separately on the Company’s consolidated balance sheets. If the carrying value exceeds the fair value less costs to sell, a loss is recognized. Assets classified as held for sale are no longer amortized. Comparative figures are reclassified to conform to the current year’s presentation.

When the Company has disposed of or classified as held for sale a component of the entity, and certain criteria are met, the results of operations of the component, including any loss recognized, are reported separately on the consolidated statements of operations as discontinued operations. Discontinued operations are presented if the component’s operations and cash flows have been, or will be, eliminated from the Company and the Company will not have significant continuing involvement in the operations of the component after the disposal. Earnings (loss) per share amounts for both continuing operations and discontinued operations are presented separately on the consolidated statements of operations and income (loss) from continuing operations. Comparative figures are reclassified to conform to the current year’s presentation.

Accounting Standards Adopted During Fiscal 2025

In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU 2023-07 on the topic of segment reporting. The standard requires additional disclosures for segment reporting. These requirements include: (i) disclosure of significant expenses that are regularly provided to the Chief Operating Decision Maker (“CODM”) and included within each reported measure of segment profit or loss (collectively referred to as the “significant expense principle”); (ii) disclosure of an amount for other segment items (equal to the difference between segment revenue less segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment and a description of their composition; (iii) annual disclosure of a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods; (iv) clarification that, if the CODM uses more than one measure of a segment's profit or loss in assessing segment performance and deciding how to allocate resources, a public entity may report those additional measures of segment profit or loss; (v) disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources; and (vi) requiring a public entity that has a single reportable segment provide all the disclosures required by the amendments in this ASU, and all existing segment disclosures in Topic 280. The guidance is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company early adopted this guidance in the first quarter of fiscal 2025 and have provided the applicable disclosures in Note 11.

Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” on the topic of income taxes. The standard requires additional disclosure for income taxes. These requirements include: (i) requiring a public entity to disclose specific categories in the rate reconciliation; (ii) disclosure of additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate); (iii) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes; (iv) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received); (v) annual disclosure of income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign; and (vi) annual disclosure of income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. For public entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this guidance in fiscal 2026 and is in the process of evaluating the new requirements. As a result, the Company has not yet determined the impact this new ASU will have on its disclosures.

In November 2024, the FASB issued ASU 2024-03 to amend the codification on “Expense Disaggregation Disclosure” (Subtopic 220-40): Income Statement - Reporting Comprehensive Income”. The standard requires additional disclosure on specific expense categories included in the expense captions presented on the statements of operations. The Company will adopt this guidance in fiscal 2028 and is in process of evaluating the new requirements. As a result, the Company has not yet determined the impact this new ASU will have on its disclosures.

  1. DISCONTINUED OPERATIONS

On October 16, 2024, the Company announced that it was revisiting capital allocation priorities within its Cybersecurity division and, as such, the Company would begin exploring opportunities for the business. At November 30, 2024, the Company determined that the assets and liabilities constituting the Cylance business, which consists of the Company’s AI and machine learning-based cybersecurity solutions previously acquired on February 21, 2019, met the criteria requiring classification as held for sale as specified in ASC 360 Property, Plant and Equipment (“ASC 360”) and met the criteria for presentation as a discontinued operations under ASC 205 Presentation of Financial Statements. While presented as a discontinued operations in its Consolidated Statement of Operations, the Company continues to operate Cylance during the time that the assets and liabilities constituting its business are held for sale.

Assets Held for Sale

For assets not covered by ASC 360, such as goodwill, the Company first considered whether any adjustment was required prior to measuring the fair value less costs to sell of the assets and liabilities associated with the Cylance business and determined none was required. The Company then estimated the fair values of assets identified as held for sale, less costs to sell, and compared them against the carrying value of the assets and determined that no impairment was present.

The following table sets forth the aggregate carrying amounts of assets and liabilities held for sale related to the discontinued operations of Cylance as of November 30, 2024 and February 29, 2024:

As at
November 30, 2024February 29, 2024
Assets
Accounts receivable, net of allowance of $1 and nil, respectively$11$20
Other receivables22
Other current assets1115
Total currents assets of discontinued operations2437
Other long-term assets33
Operating lease right-of-use assets, net810
Property, plant and equipment, net22
Intangible assets, net7696
Goodwill8787
Total long-term assets of discontinued operations176198
Liabilities
Accounts payable11
Accrued liabilities2117
Deferred revenue, current3846
Total current liabilities of discontinued operations6064
Deferred revenue, non-current1213
Operating lease liabilities1519
Total long-term liabilities of discontinued operations2732

The financial results of Cylance are presented as “loss from discontinued operations, net of tax” in the Consolidated Statements of Operations and have been removed from the presentation of results from continuing operations. The following table represents the financial results of Cylance for the three and nine months ended November 30, 2024 and November 30, 2023:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Revenue$19$23$60$74
Cost of sales11133644
Gross margin8102430
Operating expenses
Research and development9102638
Sales and marketing11153647
General and administrative451317
Amortization772020
Impairment of long-lived assets—2—2
313995124
Operating loss(23)(29)(71)(94)
Provision for income taxes————
Loss from discontinued operations, net of tax$(23)$(29)$(71)$(94)
Basic loss per share from discontinued operations$(0.04)$(0.05)$(0.12)$(0.16)
Diluted loss per share from discontinued operations$(0.04)$(0.06)$(0.12)$(0.16)

The following table represents the amortization, stock-based compensation (representing the significant non-cash operating item) and acquisition of property, plant and equipment of the discontinued operations for the three and nine months ended November 30, 2024 and November 30, 2023:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Amortization$7$7$20$20
Stock based compensation2153
Acquisition of property, plant and equipment——1—
  1. FAIR VALUE MEASUREMENTS, CASH, CASH EQUIVALENTS AND INVESTMENTS

Fair Value

The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use in pricing the asset or liability, such as inherent risk, non-performance risk and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value into three levels:

Level 1 - Unadjusted quoted prices at the measurement date for identical assets or liabilities in active markets.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 - Significant unobservable inputs that are supported by little or no market activity.

The fair value hierarchy also requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The Company’s cash and cash equivalents, accounts receivable, other receivables, accounts payable and accrued liabilities are carried at amounts that approximate their fair values (Level 2 measurement) due to their short maturities.

Recurring Fair Value Measurements

In determining the fair value of investments held, the Company primarily relies on an independent third-party valuator for the fair valuation of securities. The Company also reviews the inputs used in the valuation process and assesses the pricing of the securities for reasonableness after conducting its own internal collection of quoted prices from brokers. Fair values for all investment categories provided by the independent third-party valuator that are in excess of 0.5% from the fair values determined by the Company are communicated to the independent third-party valuator for consideration of reasonableness. The independent third-party valuator considers the information provided by the Company before determining whether a change in their original pricing is warranted.

When the Company concludes that there is a significant financing component included within a contract with a customer due to timing differences between the fulfillment of certain performance obligations and the receipt of payment for those performance obligations, the Company determines the present value of the future consideration utilizing the discount rate that would be reflected in a separate financing transaction between the customer and the Company at contract inception based upon the credit characteristics of the customer receiving financing in the contract.

For a description of how the fair value of the 2020 Debentures (as defined in Note 6) was determined, see the “Convertible debentures” accounting policies in Note 1 to the Annual Financial Statements.

Non-Recurring Fair Value Measurements

Upon the occurrence of certain events, the Company re-measures the fair value of non-marketable equity investments for which it utilizes the measurement alternative, and long-lived assets, including property, plant and equipment, operating lease ROU assets, intangible assets and goodwill if an impairment or observable price adjustment is recognized in the current period.

Non-Marketable Equity Investments Measured Using the Measurement Alternative

Non-marketable equity investments measured using the measurement alternative include investments in privately held companies without readily determinable fair values in which the Company does not own a controlling interest or have significant influence. The estimation of fair value used in the fair value measurements required the use of significant unobservable inputs, and as a result, the fair value measurements were classified as Level 3.

Impairment of Long-Lived Assets

The Company exited certain leased facilities and recorded a pre-tax and after-tax impairment charge of $1 million and $4 million during the three and nine months ended November 30, 2024, respectively, related to the operating lease right-of-use (“ROU”) assets and property, plant and equipment associated with those facilities (three and nine months ended November 30, 2023 - $1 million). The impairment was determined by comparing the fair value of the impacted ROU asset to the carrying value of the asset as of the impairment measurement date, as required under ASC 360, using Level 3 inputs. The fair value of the ROU asset was based on the estimated sublease income for certain facilities taking into consideration the estimated time period it will take to obtain a sublessor, the applicable discount rate and the sublease rate, which are considered unobservable inputs. The Company conducts an evaluation of the related liabilities and expenses and revises its assumptions and estimates as appropriate as new or updated information becomes available. The fair value measurement of ROU impaired assets is classified as Level 3.

The Company conducts regular reviews of the individual patents, both organically generated and acquired, comprising its patent portfolio. As a result of this review, for the three and nine months ended November 30, 2023, the Company determined it has an indicator of impairment, as it had ceased enforcement and abandoned the legal right and title to patents with a cost of $15 million, accumulated amortization of $7 million, and a net book value of $8 million, which is classified as an impairment of long-lived assets on the Company’s consolidated statements of operations.

Goodwill

During the third quarter of fiscal 2025, the Company reorganized its reporting structure resulting in its BlackBerry Spark reporting unit being disaggregated into two separate reporting units: UEM and Cylance. In accordance with ASC 350 Intangibles - Goodwill and Other, the Company conducted a valuation of the individual reporting units and allocated the goodwill associated with the previous BlackBerry Spark reporting unit to the UEM and Cylance reporting units using a relative fair value approach. The valuations of the reporting units were based on a combination of income approach using a discounted future cash flow model, market-based approach, and estimated exit value approaches for Cylance using the same critical accounting estimates as disclosed in Note 1 of the Annual Financial Statements. Following the assignment of assets, liabilities, and goodwill to the UEM and Cylance reporting units, the Company compared the carrying values of the reporting units against their fair values and determined no impairment was present in either reporting unit.

Cash, Cash Equivalents and Investments

The components of cash, cash equivalents and investments by fair value level as at November 30, 2024 were as follows:

Cost Basis (1)UnrealizedGainsUnrealizedLossesFair ValueCash andCashEquivalentsShort-termInvestmentsLong-termInvestmentsRestricted Cash and Cash Equivalents
Bank balances$105$—$—$105$105$—$—$—
Other investments245—29——29—
1295—134105—29—
Level 1:
Equity securities10—(10)—————
Level 2:
Term deposits, and certificates of deposits17——1710——7
Bearer deposit notes26——2626———
Commercial paper58——582731——
Non-U.S. promissory notes1——11———
Non-U.S. government sponsored enterprise notes4——4———4
Non-U.S. treasury bills1——11———
U.S. treasury bills19——1919———
126——1268431—11
Level 3:
Other investments61(1)6——6—
$271$6$(11)$266$189$31$35$11

(1) Cost basis for other investments includes the effect of returns of capital and impairment.

The components of cash, cash equivalents and investments by fair value level as at February 29, 2024 were as follows:

Cost Basis (1)UnrealizedGainsUnrealizedLossesFair ValueCash andCashEquivalentsShort-termInvestmentsLong-termInvestmentsRestricted Cash and Cash Equivalents
Bank balances$96$—$—$96$96$—$—$—
Other investments306—36——36—
1266—13296—36—
Level 1:
Equity securities10—(10)—————
Level 2:
Term deposits, and certificates of deposits21——21———21
Bearer deposit notes53——532825——
Commercial paper47——471532——
Non-U.S. promissory notes35——35305——
U.S. treasury bills10——106——4
166——1667962—25
$302$6$(10)$298$175$62$36$25

(1) Cost basis for other investments includes the effect of returns of capital and impairment.

As at November 30, 2024, the Company had non-marketable equity investments without readily determinable fair value of $35 million (February 29, 2024 - $36 million). During the three and nine months ended November 30, 2024, the Company recorded downward adjustments, net of upward adjustments, of $2 million and $1 million, respectively, to the carrying value of certain non-marketable equity investments without readily determinable fair value resulting from observable price changes in orderly transactions for identical or similar securities which have been included in investment income, net on the Company’s consolidated statements of operations. As of November 30, 2024, the Company has recorded a cumulative impairment of $3 million to the carrying value of certain other non-marketable equity investments without readily determinable fair value (February 29, 2024 - $3 million).

There wereno realized gains or losses on available-for-sale securities for the three and nine months ended November 30, 2024 and November 30, 2023.

The Company has restricted cash and cash equivalents, consisting of cash and securities pledged as collateral to major banking partners in support of the Company’s requirements for letters of credit. These letters of credit support certain leasing arrangements entered into in the ordinary course of business. The letters of credit are for terms ranging fromone month toseven years. The Company is legally restricted from accessing these funds during the term of the leases for which the letters of credit have been issued; however, the Company can continue to invest the funds and receive investment income thereon.

The following table provides a reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents as at November 30, 2024 and February 29, 2024 from the consolidated balance sheets to the consolidated statements of cash flows:

As at
November 30, 2024February 29, 2024
Cash and cash equivalents$189$175
Restricted cash and cash equivalents1125
Total cash, cash equivalents, restricted cash, and restricted cash equivalents presented in the consolidated statements of cash flows$200$200

The contractual maturities of available-for-sale investments as at November 30, 2024 and February 29, 2024 were as follows:

As at
November 30, 2024February 29, 2024
Cost BasisFair ValueCost BasisFair Value
Due in one year or less$126$126$166$166
No fixed maturity10—10—
$136$126$176$166

As at November 30, 2024 and February 29, 2024, the Company hadno available-for-sale debt securities with continuous unrealized losses.

  1. CONSOLIDATED BALANCE SHEET DETAILS

Accounts Receivable, Net of Allowance

The current estimated credit losses (“CECL”) for accounts receivable as at November 30, 2024 were $6 million (February 29, 2024 - $6 million).

The Company also has long-term accounts receivable included in Other long-term assets. The CECL for long-term accounts receivable is estimated using the probability of default method and the default exposure due to limited historical information. The exposure of default is represented by the assets’ amortized carrying amount at the reporting date.

The following table sets forth the activity in the Company’s allowance for credit losses:

Carrying Amount
Beginning balance as of February 28, 2023$1
Prior period provision for expected credit losses5
Ending balance of the allowance for credit loss as at February 29, 20246
Current period recovery for expected credit losses—
Ending balance of the allowance for credit loss as at November 30, 2024$6

The allowance for credit losses as at November 30, 2024 consists of $1 million (February 29, 2024 - $1 million) relating to CECL estimated based on days past due and region and $5 million (February 29, 2024 - $5 million) relating to specific customers that were evaluated separately.

There weretwo customers that comprised more than 10% of accounts receivable as at November 30, 2024 (February 29, 2024 -two customers comprised more than 10%).

Other Receivables

As at November 30, 2024 and February 29, 2024, other receivables included items such as receivables related to intellectual property sold in fiscal 2024, see Note 11 under the heading “Patent Sale”, and claims filed with the Ministry of Innovation, Science and Economic Development Canada relating to its Strategic Innovation Fund program’s investment in BlackBerry QNX, among other items, none of which were greater than 5% of the current assets balance.

Other Current Assets

As at November 30, 2024 and February 29, 2024, other current assets included the current portion of deferred commissions and prepaid expenses, among other items, none of which were greater than 5% of the current assets balance as at the balance sheet dates.

Property, Plant and Equipment, Net

Property, plant and equipment comprised the following:

As at
November 30, 2024February 29, 2024
Cost
BlackBerry operations and other information technology$76$76
Leasehold improvements and other48
Furniture and fixtures34
Manufacturing, repair and research and development equipment23
8591
Accumulated amortization7172
Net book value$14$19

Intangible Assets, Net

Intangible assets comprised the following:

As at November 30, 2024
CostAccumulatedAmortizationNet BookValue
Acquired technology$673$672$1
Other acquired intangibles1971934
Intellectual property1116546
$981$930$51
As at February 29, 2024
CostAccumulatedAmortizationNet BookValue
Acquired technology$673$669$4
Other acquired intangibles1971916
Intellectual property1116348
$981$923$58

For the nine months ended November 30, 2024, amortization expense related to intangible assets amounted to $13 million (nine months ended November 30, 2023 - $18 million).

Total additions to intangible assets for the nine months ended November 30, 2024 amounted to $6 million (nine months ended November 30, 2023 - $12 million). During the nine months ended November 30, 2024, additions to intangible assets primarily consisted of payments for intellectual property relating to patent maintenance, registration and license fees.

Based on the carrying value of the identified intangible assets as at November 30, 2024, and assuming no subsequent impairment of the underlying assets, the annual amortization expense for the remainder of fiscal 2025 and each of the five succeeding years is expected to be as follows: fiscal 2025 - $4 million; fiscal 2026 - $10 million; fiscal 2027 - $6 million; fiscal 2028 - $5 million; fiscal 2029 - $4 million and fiscal 2030 - $3 million.

Goodwill

Changes to the carrying amount of goodwill during the nine months ended November 30, 2024 were as follows:

Carrying Amount
Carrying amount as at February 28, 2023$489
Goodwill impairment charge(16)
Effect of foreign exchange on non-U.S. dollar denominated goodwill2
Carrying amount as at February 29, 2024475
Effect of foreign exchange on non-U.S. dollar denominated goodwill(2)
Carrying amount as at November 30, 2024$473

Other Long-term Assets

As at November 30, 2024 and February 29, 2024, other long-term assets included long-term receivables related to intellectual property sold in fiscal 2024, see Note 11 under the heading “Patent Sale”, other long-term receivables, and the long-term portion of deferred commission, among other items, none of which were greater than 5% of the total assets balance.

Accrued Liabilities

Accrued liabilities is comprised of the following:

As at
November 30, 2024February 29, 2024
Variable incentive accrual$25$14
Operating lease liabilities, current1014
Restructuring program liabilities, current portion720
Other5552
$97$100

As at November 30, 2024 and February 29, 2024, other accrued liabilities included accrued director fees, accrued vendor liabilities, payroll withholding taxes and accrued royalties, among other items, none of which were greater than 5% of the current liabilities balance in any of the periods presented.

Restructuring

During fiscal 2023 and fiscal 2024, the Company commenced restructuring programs with the objectives of reducing its annual costs and expenses relating to the Cybersecurity business, and later significantly separating and streamlining the Company’s centralized corporate functions into Cybersecurity and IoT specific teams such that the businesses may operate quasi-independently and on a profitable and cash flow positive basis. The reduction of overall Company costs has included and will continue to include rationalizing and streamlining existing central administrative functions, right-sizing cost structures within both business units including R&D and outsourced contracting, changes to overall product portfolio offerings and geographies the Company operates in and optimizing related support functions and organizational structure. Other charges and cash costs may occur as programs are implemented or changes are completed.

The following table sets forth the activity in the Company’s restructuring program liabilities:

EmployeeTerminationBenefitsFacilitiesCostsTotal
Balance as at February 28, 2023213
Charges incurred31637
Cash payments made(16)(3)(19)
Balance as at February 29, 202417421
Charges incurred11516
Cash payments made(23)(6)(29)
Balance as at November 30, 2024$5$3$8
Current portion$5$2$7
Long-term portion—11
$5$3$8

The long-term portion of the restructuring liabilities is recorded at present value, determined by measuring the remaining payments at present value using an effective interest rate of 5.4%, and the Company recorded interest expense over time to arrive at the total face value of the remaining payments.

The restructuring charges included employee termination benefits and facilities costs to better align the Company’s general and administrative and R&D cost profiles to its market competitors, create a more focused sales force and improve profitability and cash flow. Total charges incurred for the nine months ended November 30, 2024 and November 30, 2023 were $16 million and $17 million, respectively, recorded within General and administrative on the Consolidated Statements of Operations.

  1. INCOME TAXES

For the nine months ended November 30, 2024, the Company’s net effective income tax expense rate was approximately 29% compared to a net effective income tax expense rate of 37% for the nine months ended November 30, 2023. The Company’s income tax rate reflects the change in unrecognized income tax benefit, if any, and the fact that the Company has a significant valuation allowance against its deferred income tax assets; in particular, any change in loss carry forwards or research and development credits, amongst other items, is offset by a corresponding adjustment of the valuation allowance. The Company’s net effective income tax rate also reflects the geographic mix of earnings in jurisdictions with different income tax rates.

The Company’s total unrecognized income tax benefits as at November 30, 2024 were $20 million (February 29, 2024 - $20 million). As at November 30, 2024, $20 million of the unrecognized income tax benefits have been netted against deferred income tax assets andnil has been recorded within income taxes payable on the Company’s consolidated balance sheets.

The Company is subject to ongoing examination by tax authorities in certain jurisdictions in which it operates. The Company regularly assesses the status of these examinations and the potential for adverse outcomes to determine the adequacy of the provision for income taxes as well as the provisions for indirect and other taxes and related penalties and interest. While the final resolution of audits is uncertain, the Company believes the ultimate resolution of these audits will not have a material adverse effect on its consolidated financial position, liquidity or results of operations.

  1. DEBENTURES

3.00% Convertible Senior Notes

On January 29, 2024, the Company issued $200 million aggregate principal amount of 3.00% senior convertible unsecured notes (the “Notes” and, collectively with the Extension Debentures and 2020 Debentures, the “Debentures”) in an offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended.

The Notes are due on February 15, 2029 unless earlier converted, redeemed, or repurchased. Each $1,000 principal amount of the Notes is convertible into 257.5826 common shares of the Company based on the initial conversion rate, for a total of 52 million common shares at a price of $3.88 per share, subject to adjustments. Prior to the close of business on the business day immediately preceding November 15, 2028, the Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding February 15, 2029. The Company may satisfy any conversions of the Notes by paying or delivering, as the case may be, cash, its common shares or a combination of cash and its common shares, at the Company’s election (or, in the case of any Notes called for redemption that are converted during the related redemption period, solely its common shares). Covenants associated with the Notes include general corporate maintenance, existence and reporting requirements. The Notes bear interest at a rate of 3.00% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2024.

The Company had recorded the Notes, including the debt itself and all embedded derivatives, at cost less debt issuance costs of $6 million and presents the Notes as a single hybrid financial instrument. No portion of the embedded derivatives required bifurcation from the host debt contract.

The following table summarizes the change in the Notes for the nine months ended November 30, 2024:

Carrying Amount
Balance as at February 29, 2024$194
Amortization of debt issuance costs1
Balance as at November 30, 2024$195

Extension Debentures and 2020 Debentures

On November 17, 2023, the Company issued $150 million aggregate principal amount of 1.75% extendible convertible unsecured debentures (the “Extension Debentures”) in a private placement to certain controlled affiliates of Fairfax Financial Holdings Limited (“Fairfax”). The Company used the net proceeds from the issuance of the Extension Debentures, together with cash on hand, to repay its outstanding $365 million aggregate principal amount of 1.75% unsecured convertible debentures (the “2020 Debentures” and, collectively with the Extension Debentures, the “Prior Debentures”) at maturity on November 13, 2023. Aside from the maturity date, the terms of the Extension Debentures were substantially identical to those of the 2020 Debentures, except that the Extension Debentures were not listed on any stock exchange and did not involve an indenture trustee. The Extension Debentures matured on February 15, 2024.

Due to the conversion option and other embedded derivatives within the Prior Debentures, the Company elected to record the Prior Debentures, including the debt itself and all embedded derivatives, at fair value and presented the Prior Debentures as a single hybrid financial instrument. No portion of the fair value of the Prior Debentures were recorded as equity.

Each period, the fair value of the Prior Debentures were recalculated and resulting gains and losses from the change in fair value of the Prior Debentures associated with non-credit components were recognized in income, while the change in fair value associated with credit components was recognized in accumulated other comprehensive loss (“AOCL”). The fair value of the 2020 Debentures was determined using the significant Level 2 inputs interest rate curves, the market price and volatility of the Company’s listed common shares, and the significant Level 3 inputs related to credit spread and the implied discount of the 2020 Debentures at issuance. The fair value of the Extension Debentures was determined using observable interest rate curves, and the market price and volatility of the Company’s common shares.

The following table shows the impact of the changes in fair value of the 2020 Debentures for the three and nine months ended November 30, 2024 and November 30, 2023:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Income associated with the change in fair value from non-credit components recorded in the consolidated statements of operations$—$18$—$2
Realized losses associated with the change in fair value from credit components recorded in the consolidated statements of operations on maturity of the 2020 Debentures—(6)—(6)
Realized losses associated with the change in fair value from credit components released from AOCL on maturity of the 2020 Debentures—6—6
Total decrease in the fair value of the 2020 Debentures$—$18$—$2

For the three and nine months ended November 30, 2024, the Company recorded interest expense related to the Debentures of $1 million and $5 million, respectively, which has been included in investment income, net on the Company’s consolidated statements of operations (three and nine months ended November 30, 2023 - $1 million and $5 million).

Fairfax, a related party under U.S. GAAP due to its beneficial ownership of common shares in the Company after taking into account potential conversion of the Extension Debentures and the 2020 Debentures, respectively, owned the full principal amount of the Extension Debentures and $330 million principal amount of the 2020 Debentures. As such, the payment of interest on the Prior Debentures, and their repayment, to Fairfax represented related party transactions.

  1. CAPITAL STOCK

The following details the changes in issued and outstanding common shares for the nine months ended November 30, 2024:

Capital Stock andAdditional Paid-in Capital
StockOutstanding(000s)Amount
Common shares outstanding as at February 29, 2024589,233$2,948
Common shares issued for restricted share unit settlements1,187—
Stock-based compensation—21
Common shares issued for employee share purchase plan1,1633
Common shares outstanding as at November 30, 2024591,583$2,972

The Company had 592 million voting common shares outstanding,0.2 million options to purchase voting common shares,17 million RSUs and 2 million DSUs outstanding as at December 17, 2024. In addition,51.5 million common shares are issuable upon conversion in full of the Notes as described in Note 6.

  1. EARNINGS (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted earnings (loss) per share:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Net income (loss) from continuing operations for basic and diluted earnings (loss) per share available to common shareholders$12$8$(1)$20
Less: Prior Debentures fair value adjustment (1) (2) (3)—(13)——
Add: interest expense on Debentures (1) (2) (3)—1——
Net income (loss) from continuing operations for diluted earnings (loss) per share available to common shareholders$12$(4)$(1)$20
Net loss for basic and diluted loss per share available to common shareholders$(11)$(21)$(72)$(74)
Less: Prior Debentures fair value adjustment (1) (2) (3)—(13)——
Add: interest expense on Debentures (1) (2) (3)—1——
Net loss for diluted loss per share available to common shareholders$(11)$(33)$(72)$(74)
Weighted average number of shares outstanding (000’s) - basic (5)591,240584,331590,537583,559
Effect of dilutive securities (000’s)
Stock-based compensation (4) (5)2,290——5,272
Conversion of 2020 Debentures (1) (2)—49,469——
Conversion of Extension Debentures (1) (3)—4,670—1,182
Weighted average number of shares and assumed conversions (000’s) diluted593,530638,470590,537590,013
Earnings (loss) per share - reported
Basic earnings per share from continuing operations$0.02$0.01$—$0.03
Total basic loss per share$(0.02)$(0.04)$(0.12)$(0.13)
Diluted earnings (loss) per share from continuing operations$0.02$(0.01)$—$0.03
Total diluted loss per share$(0.02)$(0.05)$(0.12)$(0.13)

(1) The Company has not presented the dilutive effect of the Debentures using the if-converted method in the calculation of diluted loss per share for the three and nine months ended November 30, 2024 and nine months ended November 30, 2023, as to do so would be antidilutive. See Note 6 for details on the Debentures.

(2) The Company has presented the dilutive effect of the 2020 Debentures using the if-converted method for the period the 2020 Debentures were outstanding, assuming conversion at the beginning of the quarter for the three months ended November 30, 2023. Accordingly, to calculate diluted loss per share, the Company adjusted net loss by eliminating the fair value adjustment made to the 2020 Debentures and interest expense incurred on the 2020 Debentures for the three months ended November 30, 2023, and added the number of shares that would have been issued upon conversion to the diluted weighted average number of shares outstanding. See Note 6 for details on the 2020 Debentures.

(3) The Company has presented the dilutive effect of the Extension Debentures using the if-converted method for the period the Extension Debentures were outstanding, assuming conversion at the issuance date for the three and nine months ended November 30, 2023. Accordingly, to calculate diluted loss per share, the Company adjusted net loss by eliminating the fair value adjustment made to the Extension Debentures and interest expense incurred on the Extension Debentures for the three and nine months ended November 30, 2023 and added the number of shares that would have been issued upon conversion to the diluted weighted average number of shares outstanding. See Note 6 for details on the Extension Debentures.

(4)The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the nine months ended November 30, 2024 and the three months ended November 30, 2023, as to do so would be antidilutive.

(5)The Company has presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the three months ended November 30, 2024 and the nine months ended November 30, 2023.

  1. ACCUMULATED OTHER COMPREHENSIVE LOSS

The changes in AOCL by component net of tax, for the three and nine months ended November 30, 2024 and November 30, 2023 were as follows:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Cash Flow Hedges
Balance, beginning of period$—$—$—$(1)
Other comprehensive income (loss) before reclassification(1)—(1)1
Amounts reclassified from AOCL into net loss————
Accumulated net unrealized gains on derivative instruments designated as cash flow hedges$(1)$—$(1)$—
Foreign Currency Cumulative Translation Adjustment
Balance, beginning of period$(13)$(14)$(14)$(16)
Other comprehensive income (loss)(3)1(2)3
Foreign currency cumulative translation adjustment$(16)$(13)$(16)$(13)
Change in Fair Value From Instrument-Specific Credit Risk On Prior Debentures
Balance, beginning of period$—$(6)$—$(6)
Amounts reclassified from AOCL into net loss—6—6
Change in fair value from instruments-specific credit risk on Prior Debentures$—$—$—$—
Other Post-Employment Benefit Obligations
Actuarial losses associated with other post-employment benefit obligations$—$(1)$—$(1)
Accumulated Other Comprehensive Loss, End of Period$(17)$(14)$(17)$(14)
  1. COMMITMENTS AND CONTINGENCIES

(a)Letters of Credit

The Company had $11 million in collateralized outstanding letters of credit in support of certain leasing arrangements entered into in the ordinary course of business as of November 30, 2024. See the discussion of restricted cash in Note 3.

(b)Contingencies

Litigation

The Company is involved in litigation in the normal course of its business, both as a defendant and as a plaintiff. The Company is subject to a variety of claims (including claims related to patent infringement, purported class actions and other claims in the normal course of business) and may be subject to additional claims either directly or through indemnities against claims that it provides to certain of its partners and customers. In particular, the industry in which the Company competes has many participants that own, or claim to own, intellectual property, including participants that have been issued patents and may have filed patent applications or may obtain additional patents and proprietary rights for technologies similar to those used by the Company in its products. The Company has received, and may receive in the future, assertions and claims from third parties that the Company’s products infringe on their patents or other intellectual property rights. Litigation has been, and will likely continue to be, necessary to determine the scope, enforceability and validity of third-party proprietary rights or to establish the Company’s proprietary rights. Regardless of whether claims against the Company have merit, those claims could be time-consuming to evaluate and defend, result in costly litigation, divert management’s attention and resources and subject the Company to significant liabilities.

Management reviews all of the relevant facts for each claim and applies judgment in evaluating the likelihood and, if applicable, the amount of any potential loss. Where a potential loss is considered probable and the amount is reasonably estimable, provisions for loss are made based on management’s assessment of the likely outcome. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum amount in the range. The Company does not provide for claims for which the outcome is not probable or claims for which the amount of the loss cannot be reasonably estimated. Any settlements or awards under such claims are provided for when reasonably determinable.

As of November 30, 2024, there are no material claims outstanding for which the Company has assessed the potential loss as both probable to result and reasonably estimable; therefore, no accrual has been made. Further, there are claims outstanding for which the Company has assessed the potential loss as reasonably possible to result; however, an estimate of the amount of loss cannot reasonably be made. There are many reasons that the Company cannot make these assessments, including, among others, one or more of the following: the early stages of a proceeding does not require the claimant to specifically identify the patent claims that have allegedly been infringed or the products that are alleged to infringe; damages sought are unspecified, unsupportable, unexplained or uncertain; discovery has not been started or is incomplete; the facts that are in dispute are highly complex; the difficulty of assessing novel claims; the parties have not engaged in any meaningful settlement discussions; the possibility that other parties may share in any ultimate liability; and the often slow pace of litigation.

The Company has included the following summaries of certain of its legal proceedings though they do not meet the test for accrual described above.

Between October and December 2013, several purported class action lawsuits and one individual lawsuit were filed against the Company and certain of its former officers in various jurisdictions in the U.S. and Canada alleging that the Company and certain of its officers made materially false and misleading statements regarding the Company’s financial condition and business prospects and that certain of the Company’s financial statements contain material misstatements. The individual lawsuit was voluntarily dismissed and the consolidated U.S. class actions Stipulation of Settlement was executed effective June 7, 2022.

On July 23, 2014, the plaintiff in the putative Ontario class action (Swisscanto Fondsleitung AG v. BlackBerry Limited, et al.) filed a motion for class certification and for leave to pursue statutory misrepresentation claims. On November 17, 2015, the Ontario Superior Court of Justice issued an order granting the plaintiffs’ motion for leave to file a statutory claim for misrepresentation. On December 2, 2015, the Company filed a notice of motion seeking leave to appeal this ruling. On November 15, 2018, the Court denied the Company’s motion for leave to appeal the order granting the plaintiffs leave to file a statutory claim for misrepresentation. On February 5, 2019, the Court entered an order certifying a class comprised persons (a) who purchased BlackBerry common shares between March 28, 2013, and September 20, 2013, and still held at least some of those shares as of September 20, 2013, and (b) who acquired those shares on a Canadian stock exchange or acquired those shares on any other stock exchange and were a resident of Canada when the shares were acquired. Notice of class certification was published on March 6, 2019. The Company filed its Statement of Defence on April 1, 2019. Discovery is proceeding and the Court has not set a trial date.

On March 17, 2017, a putative employment class action was filed against the Company in the Ontario Superior Court of Justice (Parker v. BlackBerry Limited). The Statement of Claim alleges that actions the Company took when certain of its employees decided to accept offers of employment from Ford Motor Company of Canada amounted to a wrongful termination of the employees’ employment with the Company. The claim seeks (i) an unspecified quantum of statutory, contractual, or common law termination entitlements; (ii) punitive or breach of duty of good faith damages of CAD$20 million, or such other amount as the Court finds appropriate, (iii) pre- and post- judgment interest, (iv) attorneys’ fees and costs, and (v) such other relief as the Court deems just. The Court granted the plaintiffs’ motion to certify the class action on May 27, 2019. The Company commenced a motion for leave to appeal the certification order on June 11, 2019. The Court denied the motion for leave to appeal on September 17, 2019. The Company filed its Statement of Defence on December 19, 2019. The parties participated in a mediation on November 9, 2022, which did not result in an agreement. The parties attended a pre-trial conference on December 4, 2024. The Court has set a trial date of June 2, 2025. Discovery is proceeding.

Other contingencies

As at November 30, 2024, the Company has recognized $17 million (February 29, 2024 - $17 million) in funds from claims filed with the Ministry of Innovation, Science and Economic Development Canada relating to its Strategic Innovation Fund program’s investment in BlackBerry QNX. A portion of this amount may be repayable in the future under certain circumstances if certain terms and conditions are not met by the Company, which is not probable at this time.

(c)Indemnifications

The Company enters into certain agreements that contain indemnification provisions under which the Company could be subject to costs and damages, including in the event of an infringement claim against the Company or an indemnified third party. Such intellectual property infringement indemnification clauses are generally not subject to any dollar limits and remain in effect for the term of the Company’s agreements. To date, the Company has not encountered material costs as a result of such indemnifications.

The Company has entered into indemnification agreements with its current and former directors and executive officers. Under these agreements, the Company agreed, subject to applicable law, to indemnify its current and former directors and executive officers against all costs, charges and expenses reasonably incurred by such individuals in respect of any civil, criminal or administrative action that could arise by reason of their status as directors or officers. The Company maintains liability insurance coverage for the benefit of the Company, and its current and former directors and executive officers. The Company has not encountered material costs as a result of such indemnifications in the current period.

  1. REVENUE AND SEGMENT DISCLOSURES

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the CODM for making decisions and assessing performance as a source of the Company’s reportable operating segments. The CODM, who is the CEO of the Company, makes decisions and assesses the performance of the Company using three operating segments.

During the third quarter of fiscal 2025, the CODM added the segment EBITDA as a measure of profit or loss used under the “management” approach in reviewing the results of the Company’s operating segments to its existing measure of profit or loss of segment gross margin. Prior period comparatives have been recast to reflect the change in metric, including the significant operating expenses included within that metric, and the change in presentation relating to expenses associated with its facilities as disclosed in Note 1.

The CODM does not evaluate operating segments using discrete asset information. The Company does not specifically allocate assets to operating segments for internal reporting purposes.

Segment Disclosures

With the Cylance business being presented as a discontinued operations as discussed in Note 2, the Company is organized and managed asthree operating segments: Secure Communications (formerly Cybersecurity), IoT, and Licensing.

The following table shows information by operating segment for the three and nine months ended November 30, 2024 and November 30, 2023:

For the Three Months Ended
Secure Communications · IoT · Licensing · Segment Totals
November 30,November 30,November 30,November 30,
20242023202420232024202320242023
Segment revenue$74$91$62$55$7$6$143$152
Segment cost of sales202398213132
Segment gross margin (1)$54$68$53$47$5$5$112$120
Segment research and development11121615——2727
Segment sales and marketing12151110——2325
Segment general and administrative109910162025
Less amortization included in the above111—2344
Total Segment EBITDA (1)$22$33$18$12$6$2$46$47
For the Nine Months Ended
Secure Communications · IoT · Licensing · Segment Totals
November 30,November 30,November 30,November 30,
20242023202420232024202320242023
Segment revenue$205$212$170$149$16$245$391$606
Segment cost of sales676228245150100236
Segment gross margin (1)$138$150$142$125$11$95$291$370
Segment research and development36444749——8393
Segment sales and marketing34453231——6676
Segment general and administrative303525325196086
Less amortization included in the above3422681114
Total Segment EBITDA (1)$41$30$40$15$12$84$93$129

(1) A reconciliation of total segment gross margin and segment EBITDA to consolidated totals is set forth below.

Secure Communications consists of BlackBerry® UEM, BlackBerry® AtHoc® and BlackBerry® SecuSUITE®. The Company’s endpoint management platform includes BlackBerry® UEM, BlackBerry® Dynamics™, and BlackBerry® Workspaces solutions. Secure Communications revenue is generated predominantly through software licenses, commonly bundled with support, maintenance and professional services.

IoT consists of BlackBerry® QNX®, BlackBerry® Certicom®, BlackBerry Radar®, BlackBerry IVY® and other IoT applications. IoT revenue is generated predominantly through software licenses, commonly bundled with support, maintenance and professional services.

Licensing consists of the Company’s intellectual property arrangements and settlement awards.

The following table reconciles total segment gross margin for the three and nine months ended November 30, 2024 and November 30, 2023 to the Company’s consolidated totals:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Total segment gross margin$112$120$291$370
Adjustments (1):
Stock compensation expense—123
Less:
Research & development27298598
Sales and marketing23256877
General and administrative3845111133
Amortization461422
Impairment of long-lived assets1949
Prior Debentures fair value adjustment—(13)—3
Investment income, net—(5)(8)(15)
Consolidated income from continuing operations before income taxes$19$23$15$40

(1) The CODM reviews segment information on an adjusted basis, which excludes certain amounts as described below:

Stock compensation expenses - Equity compensation is a non-cash expense and does not impact the ongoing operating decisions taken by the Company’s management.

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Total Segment EBITDA$46$47$93$129
Adjustments (1):
Stock compensation expense471625
Restructuring expenses791617
Less
Corporate general and administrative expense9103124
Amortization671926
Impairment of long-lived assets1949
Prior Debentures fair value adjustment—(13)—3
Investment income—(5)(8)(15)
Consolidated income from continuing operations before income taxes$19$23$15$40

(1) The CODM reviews segment information on an adjusted basis, which excludes certain amounts as described below:

Stock compensation expenses - Equity compensation is a non-cash expense and does not impact the ongoing operating decisions taken by the Company’s management.

Restructuring expenses - Restructuring costs relate to employee termination benefits, facilities, streamlining many of the Company’s centralized corporate functions into Secure Communications (previously Cybersecurity) and IoT specific teams, and other costs pursuant to programs to reduce the Company’s annual expenses amongst R&D, infrastructure and other functions do not reflect expected future operating expenses, are not indicative of the

Company’s core operating performance, and may not be meaningful when comparing the Company’s operating performance against that of prior periods.

Patent Sale

On May 11, 2023, the Company completed the sale of certain non-core patent assets to Malikie Innovations Limited for $170 million in cash on closing, an additional $30 million in fixed consideration due by no later than the third anniversary of closing and variable consideration in the form of future royalties in the aggregate amount of up to $700 million (the “Malikie Transaction”). Pursuant to the terms of the Malikie Transaction, the Company received a license back to the patents sold, which relate primarily to mobile devices, messaging and wireless networking.

In the first quarter of fiscal 2024, the Company recognized revenue of $218 million and cost of sales of $147 million related to intellectual property sold. As at November 30, 2024, the remaining financing component on the patent sale was $6 million and will be recognized as interest income over the payment terms.

The Company estimated variable consideration from future royalty revenues using an expected value method including inputs from both internal and external sources related to patent monetization activities and cash flows, and constrained the recognition of that variable consideration based on the Company’s accounting policies and critical accounting estimates as described in Note 1. The present value of variable consideration recognized as revenue was $23 million and the amount of variable consideration constrained was $210 million. The Company evaluates its conclusions as to whether the constraints are still applicable on an ongoing basis, and will make updates when it observes a sufficient amount of evidence that amounts of variable consideration are no longer subject to constraint or the estimated amount of variable consideration has changed.

Revenue

The Company disaggregates revenue from contracts with customers based on geographical regions, timing of revenue recognition, and the major product and service types, as discussed above in “Segment Disclosures”.

The Company’s revenue, classified by major geographic region in which the Company’s customers are located, was as follows:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
North America (1)$63$62$177$418
Europe, Middle East and Africa5347141116
Other regions27437372
Total$143$152$391$606
North America (1)44.1%40.8%45.3%69.0%
Europe, Middle East and Africa37.0%30.9%36.0%19.2%
Other regions18.9%28.3%18.7%11.9%
Total100.0%100.0%100.0%100.0%

(1) North America includes all revenue from the Company’s intellectual property arrangements, due to the global applicability of the patent portfolio and licensing arrangements thereof.

Revenue, classified by timing of recognition, was as follows:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Products and services transferred over time$62$60$182$179
Products and services transferred at a point in time8192209427
Total$143$152$391$606

Revenue contract balances

The following table sets forth the activity in the Company’s revenue contract balances for the nine months ended November 30, 2024:

Accounts and Other ReceivableDeferred RevenueDeferred Commissions
Opening balance as at February 29, 2024$234$162$15
Increases due to invoicing of new or existing contracts, associated contract acquisition costs, or other40335515
Decrease due to payment, fulfillment of performance obligations, or other(411)(375)(16)
Decrease, net(8)(20)(1)
Closing balance as at November 30, 2024$226$142$14

Transaction price allocated to the remaining performance obligations

The table below discloses the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied as at November 30, 2024 and the time frame in which the Company expects to recognize this revenue. The disclosure includes estimates of variable consideration, except when the variable consideration is a sales-based or usage-based royalty promised in exchange for a license of intellectual property.

The disclosure excludes estimates of variable consideration relating to potential future royalty revenues from the Malikie Transaction, which have been constrained based on the Company’s accounting policies and critical accounting estimates and as described under “Patent Sale” in this Note 11.

As at November 30, 2024
Less than 12 Months12 to 24 MonthsThereafterTotal
Remaining performance obligations$133$3$6$142

Revenue recognized for performance obligations satisfied in prior periods

For the three and nine months ended November 30, 2024, revenue ofnil and $2 million respectively, was recognized relating to performance obligations satisfied in a prior period (three and nine months ended November 30, 2023 - $1 million and $32 million respectively).

Assets by Geography

Property, plant and equipment, intangible assets, operating lease ROU assets and goodwill, classified by geographic region in which the Company’s assets are located, were as follows:

As at
November 30, 2024February 29, 2024
Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and GoodwillTotal AssetsProperty, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and GoodwillTotal Assets
Canada$76$357$78$342
United States455841467923
Other2811129130
$559$1,309$574$1,395

Information About Major Customers

There wasone customer that comprised 18% of the Company’s revenue andone customer that comprised 15% of the Company’s revenue in the three and nine months ended November 30, 2024, respectively (three and nine months ended November 30, 2023 -two customers that comprised 29% of the Company’s revenue andone customer that comprised 37% of the Company’s revenue, due to the completed Malikie Transaction).

  1. CASH FLOW AND ADDITIONAL INFORMATION

(a) Certain consolidated statements of cash flow information related to interest and income taxes paid is summarized as follows:

Three Months EndedNine Months Ended
November 30, 2024November 30, 2023November 30, 2024November 30, 2023
Interest paid during the period$1$1$5$5
Income taxes paid during the period21125
Income tax refunds received during the period————

(b)Additional Information

Foreign exchange

The Company is exposed to foreign exchange risk as a result of transactions in currencies other than its functional currency, the U.S. dollar. The majority of the Company’s revenue in the third quarter of fiscal 2025 was transacted in U.S. dollars. Portions of the revenue were denominated in Canadian dollars, euros and British pounds. Other expenses, consisting mainly of salaries and certain other operating costs, were incurred primarily in Canadian dollars, but were also incurred in U.S. dollars, euros and British pounds. At November 30, 2024, approximately 23% of cash and cash equivalents,24% of accounts receivable and 88% of accounts payable were denominated in foreign currencies (February 29, 2024 –19%,25% and 59%, respectively). These foreign currencies primarily include the Canadian dollar, euro and British pound. As part of its risk management strategy, the Company maintains net monetary asset and/or liability balances in foreign currencies and engages in foreign currency hedging activities using derivative financial instruments, including currency forward contracts and currency options. The Company does not use derivative instruments for speculative purposes.

Interest rate risk

Cash and cash equivalents and investments are invested in certain instruments with fixed interest rates of varying maturities. Consequently, the Company is exposed to interest rate risk as a result of holding investments of varying maturities and the significant financing components within certain revenue contracts with customers. The fair value of investments, as well as the investment income derived from the investment portfolio, will fluctuate with changes in prevailing interest rates. The Company also has significant financing components within certain revenue contracts with customers and is exposed to interest rate risk as a result of discounting the future payments from customers with a fixed interest rate. The Company has also issued Notes with a fixed interest rate, as described in Note 6. The Company is exposed to interest rate risk as a result of the Notes. The Company does not currently utilize interest rate derivative instruments.

Credit risk

The Company is exposed to market and credit risk on its investment portfolio. The Company is also exposed to credit risk with customers, as described in Note 4. The Company reduces this risk from its investment portfolio by investing in liquid, investment-grade securities and by limiting exposure to any one entity or group of related entities. As at November 30, 2024, no single issuer represented more than 32% of the total cash, cash equivalents and investments (February 29, 2024 - no single issuer represented more than 30% of the total cash, cash equivalents and investments), with the largest such issuer representing bearer deposits, term deposits and cash balances with one of the Company’s banking counterparties.

Liquidity risk

Cash, cash equivalents, and investments were approximately $266 million as at November 30, 2024. The Company’s management remains focused on efficiently managing working capital balances and managing the liquidity needs of the business. Based on its current financial projections, the Company believes its financial resources, together with expected future operating cash generating and operating expense reduction activities, should be sufficient to meet funding requirements for current financial commitments and future operating expenditures not yet committed, and should provide the necessary financial capacity for the foreseeable future.

  1. SUBSEQUENT EVENTS

On December 15, 2024, the Company entered into an Equity and Asset Purchase Agreement (the “Equity and Asset Purchase Agreement”) with Arctic Wolf Networks, Inc. (“Arctic Wolf”) and certain subsidiaries of the Company and Arctic Wolf, pursuant to which and upon the terms and subject to the conditions described therein, Arctic Wolf will acquire the Company’s Cylance® endpoint security assets for a purchase price consisting of $160 million of cash, subject to certain purchase price adjustments set forth in the Equity and Asset Purchase Agreement (the “Cash Consideration”), and 5.5 million common shares in Arctic Wolf (the “Equity Consideration”). After giving effect to the purchase price adjustments to the Cash Consideration, the Company will receive approximately $80 million of the Cash Consideration and the Equity Consideration at closing of the transaction, and approximately $40 million of the Cash Consideration on the one-year anniversary of closing.

The Equity and Asset Purchase Agreement contains customary representation, warranties, covenants and indemnification made by the Company and Arctic Wolf. In addition, the Equity and Asset Purchase Agreement provides that, on the closing date of the transaction, the Company and Arctic Wolf will enter into (i) a non-exclusive patent license agreement, (ii) a partner agreement pursuant to which the Company will agree to resell certain products and services of Arctic Wolf, and (iii) a strategic customer support agreement, pursuant to which Arctic Wolf will agree to provide certain customer support services to the Company.

Completion of the transaction is conditional upon the provision of customary closing deliverables and satisfaction of customary conditions.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.